ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537 | +37.0% | 20 | +81.8% | 0.00% | – |
| Q2 2023 | $392 | +40.5% | 11 | 0.0% | 0.00% | – |
| Q1 2023 | $279 | -37.4% | 11 | 0.0% | 0.00% | – |
| Q4 2022 | $446 | – | 11 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 11 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 11 | -42.1% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 19 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 19 | -38.7% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 31 | -3.1% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 32 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 32 | +33.3% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 24 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |